OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
TaiwanJ Pharmaceuticals Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
TaiwanJ Pharmaceuticals Co OCF Yield % Related Terms
TaiwanJ Pharmaceuticals Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6549 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiwanJ Pharmaceuticals Co OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where TaiwanJ Pharmaceuticals Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiwanJ Pharmaceuticals Co (ROCO:6549) has a OCF Yield % of -4.23 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on TaiwanJ Pharmaceuticals Co and its competitors. According to the industry distribution chart, TaiwanJ Pharmaceuticals Co ranks #558 out of 1410 companies in the Biotechnology industry, placing it in the top 39.6%.
Is TaiwanJ Pharmaceuticals Co's OCF Yield % too high?
TaiwanJ Pharmaceuticals Co's current OCF Yield % is -4.23. Based on the distribution chart, TaiwanJ Pharmaceuticals Co ranks #558 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, TaiwanJ Pharmaceuticals Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiwanJ Pharmaceuticals Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TaiwanJ Pharmaceuticals Co ranks #558 out of 1410 companies for OCF Yield %. This puts TaiwanJ Pharmaceuticals Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on TaiwanJ Pharmaceuticals Co and its competitors. TaiwanJ Pharmaceuticals Co's current OCF Yield % is -4.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiwanJ Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co (ROCO:6549) is currently considered Possible Value Trap. The stock's GF Value™ is NT$11.96, compared to a current price of NT$7.13 — trading 40.4% below its estimated fair value. The current OCF Yield % is -4.23. TaiwanJ Pharmaceuticals Co's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For TaiwanJ Pharmaceuticals Co (ROCO:6549), the current OCF Yield % is -4.23 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiwanJ Pharmaceuticals Co (ROCO:6549) Overvalued in 2026?
Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co stock appears to be undervalued.
The current stock price of NT$7.13 is trading 40.4% below its estimated GF Value™ of NT$11.96.
GuruFocus considers TaiwanJ Pharmaceuticals Co to be Possible Value Trap.
Key valuation signals for ROCO:6549:
OCF Yield %: -4.23
GF Value™: NT$11.96 vs. price of NT$7.13 (40.4% below fair value)
No single metric tells the full story. See the ROCO:6549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
42GF Score
Get the complete analysis for ROCO:6549
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6549 has been successfully added to your 
